Showing results (1701-1710 of 1,736) with videos related to

Sort By:
Pageof 174
Medrxiv : the Preprint Server for Health Sciences|June 6, 2022
Generalizable Long COVID Subtypes: Findings from the NIH N3C and RECOVER ProgramsJustin T Reese, Hannah Blau, Timothy Bergquist, et al.
Gastroenterology|December 1, 2009
Genome-wide association analysis in primary sclerosing cholangitisTom H Karlsen, Andre Franke, Espen Melum, et al.
Ebiomedicine|December 23, 2022
Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmesJustin T Reese, Hannah Blau, Elena Casiraghi, et al.
Arxiv|August 23, 2023
The Brain Tumor Segmentation (BraTS) Challenge 2023: Brain MR Image Synthesis for Tumor Segmentation (BraSyn)Hongwei Bran Li, Gian Marco Conte, Qingqiao Hu, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Critical assessment of missense variant effect predictors on disease-relevant variant dataRuchir Rastogi, Ryan Chung, Sindy Li, et al.
Human Genetics|March 21, 2025
Critical assessment of missense variant effect predictors on disease-relevant variant dataRuchir Rastogi, Ryan Chung, Sindy Li, et al.
Journal of Digital Imaging|September 28, 2022
The 2021 SIIM-FISABIO-RSNA Machine Learning COVID-19 Challenge: Annotation and Standard Exam Classification of COVID-19 Chest RadiographsParas Lakhani, J Mongan, C Singhal, et al.
Hepatology (Baltimore, Md.)|March 23, 2011
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9Marcel Janse, Laetitia E Lamberts, Lude Franke, et al.
Plos One|September 3, 2010
Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitisJohannes R Hov, Verena Keitel, Jon K Laerdahl, et al.
Hepatology (Baltimore, Md.)|January 12, 2020
Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic OpportunitiesBenjamin Goeppert, Trine Folseraas, Stephanie Roessler, et al.
Pageof 174